4/15/2010

It is crucial for the U.S. to develop a data system on blood transfusion-related adverse events that would be readily available and accessible, making it easier to track these events, said Dr. Paul Ness, editor of the journal Transfusion. The hemovigilance system would provide hospitals with the opportunity to measure whether the changes they make have an effect on patient outcomes.

Related Summaries